Tag Archives: CLBS

Monday’s Highlights at Noon: Rosetta Genomics Ltd (ROSG), RXi Pharmaceuticals Corp (RXII), Opko Health (OPK), CytRx Corporation (CYTR), Caladrius Biosciences (CLBS)

So far Monday, November 12, NASDAQ is down -4.57% and the S&P is down -2.63%. Here are this morning’s most active stocks: Rosetta Genomics Ltd (ROSG – Research Report), RXi Pharmaceuticals Corp (RXII – Research Report), Opko Health (OPK –

Friday’s Midday Movers: Orexigen (OREX), Rex Energy (REXX), American Green Inc (ERBB), Caladrius Biosciences (CLBS), Acura Pharmaceuticals (ACUR)

So far Friday, November 9, NASDAQ is down -2.69% and the S&P is down -2.11%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Orexigen (OREX – Research Report), Rex Energy (REXX – Research

Friday’s Highlights at Noon: Orexigen (OREX), Rex Energy (REXX), American Green Inc (ERBB), Caladrius Biosciences (CLBS), Acura Pharmaceuticals (ACUR)

So far Friday, November 9, NASDAQ is down -2.69% and the S&P is down -2.1%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Orexigen (OREX – Research Report), Rex Energy (REXX – Research

H.C. Wainwright Remains a Buy on Caladrius Biosciences

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS) today and set a price target of $12. The company’s shares opened today at $4.26. According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars

H.C. Wainwright Reiterates Their Buy Rating on Caladrius Biosciences

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS), with a price target of $12. The company’s shares closed yesterday at $5.75. According to TipRanks.com, Selvaraju is ranked 0 out

Tuesday’s Midday Movers: Amedica (AMDA), Curis Inc (CRIS), Caladrius Biosciences (CLBS), Endocyte (ECYT), Cree (CREE)

So far Tuesday, March 6, NASDAQ is up 0.17% and the S&P is down -1.22%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Amedica (NASDAQ:AMDA), Curis Inc (NASDAQ:CRIS), Caladrius Biosciences (NASDAQ:CLBS), Endocyte (NASDAQ:ECYT)